There are no published human clinical trials of Dihexa, and the closest human evidence in its drug class Athira's fosgonimeton failed its Phase 3 Alzheimer's endpoint in 2024

Benefits Tesamorelin + Ipamorelin is believed to help with: Targeted visceral fat reduction: Tesamorelin has been shown to reduce VAT area and improve VAT quality and lipid profiles while sparing subcutaneous fat, supporting both health and aesthetics. Lean mass and recovery support: Ipamorelin selectively boosts GH/IGF1 to promote protein synthesis, lean mass, strength, and exercise recovery with a favorable sideeffect profile compared with many GH secretagogues. Improved recomposition and performance: Stacking the two can yield better waistlines, tighter midsections, stronger training sessions, and more resilient recovery than either alone when combined with strength training and adequate protein. Labguided, cyclical use: Protocols often run 8-12 weeks with 5dayson/2daysoff injections, periodic breaks, and monitoring of IGF1, glucose, and lipids to align benefits with safety.

The evidence is mixed, with some studies suggesting DSIP does not induce tolerance while user reports sometimes indicate diminishing returns with daily use
Until research clarifies these questions, avoidance is the safest approach
Will Glutathione Lighten My Skin
Lets unpack the science, the results, and what it means for your joints